These findings underscore the significance of WNT7A in HNSCC progression and propose the targeting of key molecules within the FZD7/JAK1/STAT3 pathway as a promising strategy for precise treatment of HNSCC. This evidence concerns the gene WNT7A and head and neck squamous cell carcinoma.